Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia - Nishihori, T.; Alekshun, T.J.; Sullivan, D.M.; Kharfan-Dabaja, M.A.; Raychaudhuri, J.; Ochoa-Bayona, J.L.; Shain, K.; Yarde, D.N.; Oliviera, V.; Pidala, J.; Fulp, W.; Chen, D.-T.; et al. (Biology of Blood & Marrow Transplantation, 2011)